¹⁸F-FDG PET/CMR in cardiac sarcoidosis: A wild card in the deck?

J Nucl Cardiol. 2022 Apr;29(2):765-767. doi: 10.1007/s12350-020-02427-3. Epub 2020 Nov 3.

Authors

Carmela Nappi¹, Andrea Ponsiglione¹, Massimo Imbriaco¹, Alberto Cuocolo²

Affiliations

¹ Department of Advanced Biomedical Sciences, University Federico II, Via Pansini 5, 80131, Naples, Italy.
² Department of Advanced Biomedical Sciences, University Federico II, Via Pansini 5, 80131, Naples, Italy. cuocolo@unina.it.

PMID: 33145740
DOI: 10.1007/s12350-020-02427-3

No abstract available

Publication types

Editorial
Comment

MeSH terms

Cardiomyopathies* / diagnostic imaging
Fluorodeoxyglucose F18
Humans
Positron-Emission Tomography
Radiopharmaceuticals
Sarcoidosis* / diagnostic imaging

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18